High dose of histone deacetylase inhibitors affects insulin secretory mechanism of pancreatic beta cell line
Objective. Histone deacytylase inhibitors (HDACis) inhibit the deacetylation of the lysine residue of proteins, including histones, and regulate the transcription of a variety of genes. Recently, HDACis have been used clinically as anti-cancer drugs and possible anti-diabetic drugs. Even though HDAC...
Guardado en:
Autor principal: | Yamato Eiji |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Sciendo
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a1331ef46d6d46e983349cdeb35e1fdb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Diabetic Retinopathy and Insulin Insufficiency: Beta Cell Replacement as a Strategy to Prevent Blindness
por: Eli Ipp
Publicado: (2021) -
Temporal characterization of the insulin resistance during puberty in mice
por: Teixeira Pryscila D.S., et al.
Publicado: (2021) -
A Rare Case of Subcutaneous Insulin Resistance Presumed to be due to Paraneoplastic Process in Pancreatic Adenocarcinoma
por: Kacey Chae, MD, et al.
Publicado: (2021) -
Beta-cell failure rather than insulin resistance is the major cause of abnormal glucose tolerance in Africans: insight from the Africans in America study
por: Thomas Hormenu, et al.
Publicado: (2021) -
Genetic variants associated with beta-cell function and insulin sensitivity potentially influence bile acid metabolites and gestational diabetes mellitus in a Chinese population
por: Hui Wang, et al.
Publicado: (2021)